From access to uptake: Reflections from EMIG’s quarterly meeting
CF presented at the Ethical Medicines Industry Group quarterly [...]
NICE 2026: The goalposts have moved
Three to six months. That is the time saving [...]
NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK
In a move that has triggered disappointment across the [...]
